Efficacy and safety of the Shexiang Baoxin Pill for the treatment of coronary artery disease not amenable to revascularisation: study protocol for a randomised, placebo-controlled, double-blinded trial. [electronic resource]
Producer: 20180830Description: e018052 p. digitalISSN:- 2044-6055
- Aged
- Aortic Dissection -- etiology
- Angina Pectoris -- etiology
- C-Reactive Protein -- metabolism
- Coronary Artery Disease -- complications
- Coronary Vessels -- pathology
- Double-Blind Method
- Drugs, Chinese Herbal -- pharmacology
- Electrocardiography
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Natriuretic Peptide, Brain -- metabolism
- Patient Readmission
- Percutaneous Coronary Intervention
- Pulmonary Embolism -- etiology
- Research Design
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.